Potential advantage of studying the lymphatic drainage by sentinel node technique and SPECT-CT image fusion for pelvic irradiation of prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 4, 2006, Pages 1100-1104

  Krengli, Marco ^a   Ballarè, Andrea ^a   Cannillo, Barbara ^b   Rudoni, Marco ^a   Kocjancic, Ervin ^a   Loi, Gianfranco ^b   Brambilla, Marco ^b   Inglese, Eugenio ^a   Frea, Bruno ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b University Hospital Maggiore della Carita   (Italy)

Author keywords

Pelvic irradiation; Prostate cancer; Sentinel node; Single photon emission computed tomography

Indexed keywords

COMPUTERIZED TOMOGRAPHY; IMAGE ANALYSIS; IRRADIATION; ONCOLOGY; PATIENT TREATMENT; RADIOTHERAPY;

PELVIC IRRADIATION; PROSTATE CANCER; SENTINEL NODES; SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY;

MEDICAL IMAGING;

TECHNETIUM 99M;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; LYMPHATIC DRAINAGE; MALE; METASTASIS; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; SENTINEL LYMPH NODE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PELVIS; PROGNOSIS; PROSTATIC NEOPLASMS; SENTINEL LYMPH NODE BIOPSY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33750332999     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.06.047     Document Type: Article

References (21)

1. Bolla M., Collette L., Blank L., et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial. Lancet 360 (2002) 103-106
2. Hanks G.E., Pajak T.F., Porter A., et al. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol 21 (2003) 3972-3978
3. Jacob R., Hanlon A.L., Horwitz E.M., et al. Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement. Int J Radiat Oncol Biol Phys 61 (2005) 695-701
4. Roach III M., DeSilvio M., Lawton C., et al. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 21 (2003) 1904-1911
5. Forman J.D., Lee Y., Roberson P., et al. Advantages of CT and beam's eye view display to confirm the accuracy of pelvic lymph node irradiation in carcinoma of the prostate. Radiology 186 3 (1993) 889-892
6. Ashman J.B., Zelefsky M.J., Hunt M.S., et al. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 765-771
7. Taylor A., Rockall A.G., Reznek R.H., et al. Mapping pelvic lymph nodes: Guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 1604-1612
8. Shih H.E., Harisinghani M., Zietman A., et al. Mapping of nodal disease in locally advanced prostate cancer: Rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy. Int J Radiat Oncol Biol Phys 63 (2005) 1262-1269
9. Jeschke S., Nambirajan T., Leeb K., et al. Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 173 (2005) 1943-1946
10. Kizu H., Takayama T., Fukuda M., et al. Fusion of SPECT and multidetector CT images for accurate localization of pelvic sentinel lymph nodes in prostate cancer patients. J Nucl Med Technol 33 (2005) 78-82
11. Malmstrom P.U. Lymph node staging in prostatic carcinoma revisited. Acta Oncol 44 (2005) 593-598
12. Rudoni M., Sacchetti G.M., Leva L., et al. Recent applications of the sentinel lymph node concept: Preliminary experience in prostate cancer. Tumori 88 (2002) S16-S17
13. Wawroschek F., Vogt H., Wengenmair H., et al. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int 70 (2003) 303-310
14. Ganswindt U., Paulsen F., Corvin S., et al. Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition. BMC Cancer 5 (2005) 91
15. Brambilla M., Cannillo B., Dominietto M., et al. Characterization of ordered-subsets expectation maximization with 3D post-reconstruction Gauss filtering and comparison with filtered backprojection in 99mTc SPECT. Ann Nucl Med 19 (2005) 75-82
16. Bailey D.L., Snowdon G., Cooper R.G., et al. The use of molecular sieves to produce point sources of radioactivity. Phys Med Biol 49 (2004) 21-29
17. Silva Jr. N., Anselmi C.E., Anselmi O.E., et al. Use of the gamma probe in sentinel lymph node biopsy in patients with prostate cancer. Nucl Med Commun 26 (2005) 1081-1086
18. Takashima H., Egawa M., Imao T., et al. Validity of sentinel lymph node concept for patients with prostate cancer. J Urol 171 (2004) 2268-2271
19. Heidenreich A., Varga Z., and Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: High incidence of lymph node metastasis. J Urol 167 (2002) 1681-1686
20. Golimbu M., Morales P., Al-Askari S., et al. Extended pelvic lymphadenectomy for prostatic cancer. J Urol 121 (1979) 617-620
21. Clark T., Parekh D.J., Cookson M.S., et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 169 (2003) 145-147